FIELD: medicine.
SUBSTANCE: invention relates to derivatives of a new heterocyclic system: 1,8-diarylbis[1,2,4]triazolo[4,3-b:3',4'-f][1,2,4,5]tetrazines of the general formula IIa-c, which have anti-glycating, anti-glycoxidation and antiplatelet activities.
EFFECT: provided is ability to block the formation of glycation end products and pathological consequences of this process.
1 cl, 4 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 3-GUANIDINOAZOLO[1,2,4,5]TETRAZINES HAVING ANTIGLYCATING ACTIVITY AND A PROCESS FOR THEIR PREPARATION | 2017 |
|
RU2668971C1 |
| SODIUM SALT OF DIETHYL ETHER OF 4-OXO-1,4-DIHYDROPYRAZOLO[5,1-C]-1,2,4-TRIAZINE-3,8-DICARBOXYLIC ACID MONOHYDRATE | 2015 |
|
RU2612300C1 |
| 2-(5-NITRONYLFURAN-2-YL)-5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-A]PYRIMIDIN-7(4N)-ONE AND SALTS THEREOF | 2018 |
|
RU2716715C2 |
| USE OF HETEROCYCLIC HYDRAZONES AS AGENTS HAVING ANTIGLYCATING ACTIVITY | 2016 |
|
RU2658819C2 |
| PHARMACEUTICAL COMPOSITION OF ANTIGLYCATING ACTIVITY IN SOLID DOSAGE FORM IN FORM OF CAPSULES AND METHOD FOR PREPARATION THEREOF | 2019 |
|
RU2738804C1 |
| AZO DERIVATIVES OF 5-AMINOSALICYLIC ACID, CAPABLE OF INHIBITING FORMATION OF END PRODUCTS OF GLYCATION | 2024 |
|
RU2837878C1 |
| ANTI-TUBERCULOSIS AGENTS BEING 3,7-DISUBSTITUTED [1,2,4]TRIAZOLO[1,5-b][1,2,4,5]TETRAZINES | 2022 |
|
RU2802300C1 |
| SODIUM SALT OF 3-NITRO-4-OXO-1,4-DIHYDROPYRAZOLO[5,1-c]-1,2,4-TRIAZINE-8-CARBOXYLIC ACID, DIHYDRATE | 2016 |
|
RU2641107C1 |
| APPLICATION OF SULFASALAZINE AS AN INHIBITOR OF THE FORMATION GLYCATION END PRODUCTS | 2017 |
|
RU2680844C1 |
| AZO-DERIVATIVES OF AMINOPHENOLS, CAPABLE OF INHIBITING FORMATION OF ADVANCED GLYCATION END PRODUCTS | 2024 |
|
RU2839138C1 |
